Dana Wishengrad

Dana Wishengrad has extensive experience in the field of clinical sciences and oncology. Dana currently holds the position of Director of Clinical Sciences at Arcus Biosciences since May 2021. Prior to this, they worked at ExecuPharm as a Senior Clinical Scientist in Oncology at Merck from November 2015 to May 2021. Dana also held roles at Bristol-Myers Squibb as a Protocol Manager for late phase oncology from September 2014 to October 2015 and as a Protocol Manager for the Expanded Access Program from December 2013 to September 2014. Before joining Bristol-Myers Squibb, Dana worked at Merck as a Global Trial Manager in Early Stage Development from October 2009 to November 2013 and as an Early Clinical Scientist in Experimental Medicine from November 2006 to September 2009. Dana started their career as a Research Analyst at Vanderbilt University Medical Center in 2004.

Dana Wishengrad earned a Bachelor of Arts degree in Neuroscience and Behavior from Wesleyan University between 1989 and 1993.